Last reviewed · How we verify

Skin antisepsis

University of British Columbia · FDA-approved active Small molecule

Skin antisepsis reduces or eliminates microorganisms on the skin surface to prevent infection during medical procedures.

Skin antisepsis reduces or eliminates microorganisms on the skin surface to prevent infection during medical procedures. Used for Preoperative skin antisepsis prior to surgical procedures, Skin disinfection prior to invasive medical procedures.

At a glance

Generic nameSkin antisepsis
SponsorUniversity of British Columbia
Drug classTopical antiseptic
ModalitySmall molecule
Therapeutic areaInfection Prevention
PhaseFDA-approved

Mechanism of action

Antiseptic agents work by disrupting bacterial cell membranes, denaturing proteins, or interfering with microbial metabolism, thereby killing or inhibiting the growth of pathogenic organisms on the skin. This reduces the microbial load at the site of surgical or invasive procedures, lowering the risk of surgical site infections and other procedure-related infections.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results